Advancing evenhanded solutions to our nation's challenges. Focusing heavily on substance use disorders and the drug poisoning crisis. 501(c)(3).
Joined July 2018
- Tweets 666
- Following 397
- Followers 298
- Likes 1,207
122 Photos and videos
Pinned Tweet
11 Feb 2023
We are honored to welcome new board members @LaTonyaCLC, @MarshaPhDRN, and Ronne Ostby. Their leadership will bolster our efforts to promote evenhanded responses to the #substanceusedisorder, drug poisoning, and #mentalhealth crises.
accesswire.com/viewarticle.a…
ALT Collage of headshots of Ms. Pinkard, Dr. Stanton, and Ms Ostby.
1
2
6
573
4 Feb 2025
Last week, the FDA approved the first new pain reliever in 20 years. This non-opioid targets sodium channels to treat acute pain. While trials showed its effectiveness in post-surgical patients, its benefits for chronic pain may be limited. Learn more: fda.gov/news-events/press-an…
39
8 Jul 2024
Tomorrow, our Chairman @MCBtweets will moderate a Congressional briefing on enhancing decision-making and patient outcomes with AI, featuring policymakers, physicians, tech innovators, and patient care advocates. RSVP here: forms.office.com/Pages/Respo…
1
1
46
1 Feb 2024
In response to an activist group opposing FDA funding for a substance misuse surveillance program, CUSP sent FDA a letter underscoring RADARS System's role in researching and responding to medication diversion, substance misuse, and addiction. Read letter: centerforuspolicy.org/cusp-l…
55
26 Dec 2023
Thank you @GovKathyHochul for signing S2677/A463 to help ensure patients get the information they need when faced with a denial due to #steptherapy. Thank you @NeilBreslin46 and @johnmcdonald108 for your leadership! #HappyHolidays
1
1
58
6 Nov 2023
The Journal of Opioid Management has published a special edition, edited by our Chairman @MCBtweets and featuring our Senior Fellow @LynnRWebsterMD. It explores legal and policy responses to improper #pain management and #opioid misuse. Learn more: finance.yahoo.com/news/journ…
58
19 Sep 2023
Considering a career in addiction policy? Tune into the virtual info session on the M.S. in Addiction Policy and Practice program at Georgetown University's Graduate School of Arts & Sciences on Sept. 25 at noon hosted by @ReginaLabelle. Register here: gradapply.georgetown.edu/reg…
1
1
54
8 Aug 2023
.@InHealthPolicy reported FDA’s denial of CUSP’s Citizen Petition to classify risk assessment software a misbranded medical device and enforce a recall. Procedural grounds cited, but FDA will evaluate the matter for potential further actions. Learn more: insidehealthpolicy.com/daily…
2
3
3
106
7 Aug 2023
On July 28, 2023, @US_FDA approved the second OTC #naloxone product, helping increase consumer access to naloxone without a prescription. It is anticipated to be available early 2024 to #harmreduction organizations and state governments. Learn more here: fda.gov/news-events/press-an…
1
38
1 Aug 2023
The @US_FDA denied the Citizen Petition by CUSP to deem a #SUD risk-scoring clinical decision support software a misbranded medical device. Despite the decision being procedural, the health and safety concerns raised remain significant. Learn more here: finance.yahoo.com/news/fda-d…
2
2
2
91
26 May 2023
Thanks, @axios, for covering our citizen petition to protect people with #pain and others who need controlled medications. We appreciate your objectivity.
An effort to get the FDA to pull a widely used prescription drug monitoring software package off the market is stoking a broader debate over how much technology is influencing opioid prescribing.
trib.al/5PWlJxa
1
45
17 May 2023
A more direct, efficient approach to enhancing access to #methadone for #OUD is to reduce regulatory burdens and delays hindering the establishment of OTP medication units in pharmacies. finance.yahoo.com/news/healt…
3
4
6
880
Center for U.S. Policy retweeted
30 Apr 2023
👏🏼👏🏼👏🏼👏🏼
28 Apr 2023
3
6
128
Center for U.S. Policy retweeted
30 Apr 2023
Excellent News! This is a very good thing.
28 Apr 2023
2
2
48
Center for U.S. Policy retweeted
28 Apr 2023
A citizen's petition to #FDA asks that #NarxCare be taken off the market. #NarxCare software analyzes drug data to give patients “risk scores,” but critics say its a misbranded medical device that harms patients. @BambooHLTH #cpp #opioids #chronicpain bit.ly/41IQvZI
1
9
17
502
Center for U.S. Policy retweeted
29 Apr 2023
When patients have inadequate access to medically necessary controlled medications, the harms can include relegation to the illicit drug market, exposure to substances adulterated with illegal fentanyl, prosecution and incarceration, drug poisoning, suicide, and death.
28 Apr 2023
2
7
16
716
29 Apr 2023
Thank you for your courageous thought leadership and advocacy, @jenndoliva. 🙏
1
1
151
28 Apr 2023
Today, we filed a Citizen Petition asking @US_FDA to deem software that creates patient “risk scores” a misbranded device and to take action to prevent serious, adverse health consequences and death. Read the petition here: centerforuspolicy.org/fdacp2… #OUD #pain #anxiety #insomnia
15
46
94
13,433
Center for U.S. Policy retweeted
28 Apr 2023
JMR is extending an open call for submissions in 2023! We welcome manuscripts spanning original research, best practices, commentaries about patient safety & related matters relevant to medical regulators in the U.S. & around the world. bit.ly/3Qrycmt #callforpapers
6
7
302
Center for U.S. Policy retweeted
30 Mar 2023
ICYMI: “Demanding Better: A Case for Increased Funding & Involvement of State Medical Boards in Response to America’s Drug Abuse Crisis,” by authors from @dcbalaw & @USPolicyCenter: bit.ly/3oEAqjX
3
2
144
Center for U.S. Policy retweeted
17 Apr 2023
Since launching, the #HealthCare Litigation Tracker—a free digital resource that tracks and analyzes health care litigation in the US—has added new cases and issues to the website.
Learn about the 81 cases, including #Braidwood v Becerra, and 11 issues: litigationtracker.law.george…
1
8
18
8,734